FNDC5 and obesity due to melanocortin 4 receptor deficiency: Recent reports have indicated that irisin is associated with metabolic disorders, such as obesity (11), insulin resistance (IR) (12), musculoskeletal health (13), type 1 diabetes mellitus (T1DM) (14), and T2DM (15).